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Abstract
The prevalence of atrial fibrillation and the likelihood of undergoing concomitant surgical 
ablation at the time of open heart surgery are increasing. Currently, the conventional cut-
and-sew Maze procedure has been predominantly replaced by Cox-Maze IV procedure, in 
which new energy sources such as radiofrequency energy and/or cryoablation are applied. 
Cox-Maze IV procedure has been associated with lower rate of complications than a cut-
and-sew procedure. However, some previous studies reported the lower success rate of 
Cox-Maze IV procedure, possibly because radiofrequency ablation or cryoablation cannot 
always achieve transmurality. For the success of surgical ablation, achieving transmural-
ity, defined as complete atrial wall thickness of fibrotic changes, is of paramount impor-
tance. A review of previous articles regarding histopathological changes of the atrial tissue 
following surgical ablation is performed. The effectiveness of new energy sources such as 
radiofrequency and cryoablation in terms of histological transmurality is discussed.
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1. Introduction
Surgical ablation for atrial fibrillation (AF) has been under continuous development for over 
two decades. The most recent guidelines for the surgical treatment of AF reported by the 
Society of Thoracic Surgeons (STS) state that surgical ablation for persistent AF can be per-
formed without adding operative risk and is recommended at the time of concomitant mitral 
valve operations, isolated aortic valve operations, isolated coronary artery bypass grafting, 
and combined aortic valve and coronary artery bypass surgery (class I strength of recom-
mendation) [1]. Surgical ablation is also recommended to symptomatic AF refractory to 
medical or catheter-based therapy in the absence of structural heart disease (class II strength 
of recommendation) [1].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The first clinical surgical ablation for AF was introduced by Dr. James Cox in 1987, and was 
termed the Cox-Maze I. The successful 22 cases were reported in 1991 [2]. Over the subse-
quent years, the operation evolved into the Cox-Maze III or the cut-and-sew Maze [3], which 
has been applied extensively in clinical practice [4]. In the meantime, the introduction of abla-
tion technology has significantly changed the attitude. Damiano et al. employed a combina-
tion of radiofrequency energy and cryoablation to replace several of the Cox-Maze III cut and 
sew lesions and termed this procedure as the Cox-Maze IV [5, 6]. Finally, the lesion sets of the 
Cox-Maze IV have evolved to its current form [7, 8] (Figure 1).
Khargi et al. reported that conventional cut-and-sew Cox-Maze III procedure is getting less 
frequently performed, and alternative sources of energy were predominantly used in all 
surgical ablation cases (92.0%), and almost always (98.4%) in concomitant procedures [9]. 
Cryoablation is employed as an alternative source of energy [10–12]. As compared to radiofre-
quency and cryoablation, other energy sources such as microwave, laser, and high-frequency 
ultrasound have proven less effective, and are not commercially available now [13–18].
2. Electrophysiologic basis of atrial fibrillation
It was documented that all AF is characterized by the presence of two or more large macroreen-
trant circuits in the atria simultaneously [19]. Haïssaguerre et al. first detected the focal triggers 
of atrial ectopic beats [20]. They noted that the ectopic foci are mainly (>90%) located in and 
Figure 1. Scheme of the bi-atrial Cox-Maze procedure IV utilizing radiofrequency (RF) or cryoablation energy sources.
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around the orifices of the pulmonary veins and the remaining are located in other sites such 
as right atrium, left atrium, crista terminalis, and left atrial appendage. The findings of their 
paper, which reported that the triggers were successfully treated with radiofrequency ablation, 
led to an explosion of efforts by a number of cardiologists and cardiac surgeons to treat AF 
with catheter ablation and surgical techniques, respectively. The concept of treating AF was 
originally focused on isolating the pulmonary veins, either by catheters or surgical devices.
However, AF produces unfavourable changes in atrial function and structure, which is called 
remodeling [21]. After many years of paroxysmal AF, the macroreentrant circuits of AF can 
become self-perpetuating. At this point, paroxysmal AF can become long-standing or per-
sistent AF, and the underlying electrophysiologic culprit is no longer the focal triggers, but 
rather the macroreentrant circuits themselves. Therefore, for long-standing or persistent AF, 
simple isolation of pulmonary veins is not an effective treatment because the focal triggers do 
not account for onset of AF for this type of AF. In these patients, it is necessary to interrupt the 
macroreentrant circuits by placing additional linear lesions in the atria. This concept has led 
to a surgical ablation technique called Cox-Maze procedure.
3. Cryoablation
3.1. Introduction of cryoablation
The era of cryosurgery began with the development of automated cryosurgical equipment in 
the 1960s. Cooper et al. described cryosurgical resection of parenchymal organs using liquid 
nitrogen-refrigerated clamp in 1966 [22]. Cryosurgery has been an integral part of the surgi-
cal treatment of cardiac arrhythmias since the 1970s. With the recent technological develop-
ment of cryoablation devices, the use of cryothermy in the treatment of cardiac arrhythmias 
is increasing.
Cryoablation is effective in producing electrical silent ablation lines, and can be used judi-
ciously safely without injuring surrounding structures such as coronary arteries and valve 
tissue.
3.2. Mechanisms of tissue injury in cryoablation
Gage et al. described the mechanisms of tissue injury in cryosurgery [23]. The adverse effect of 
low temperature on cells begins as temperature falls into the hypothermic range. The function 
and structure of cells are stressed, and cell metabolism progressively fails. As the temperature 
goes further down and falls into the freezing range, water is crystallized, which causes more 
serious consequences than the earlier cooling. Ice crystal formation first occurs in the extra-
cellular spaces, and with further cooling, it occurs within the cell. Intracellular ice formation 
requires temperatures colder than −40°C. Once intracellular ice is formed, it disrupts organ-
elles and cell membranes, and cell death is practically certain.
The progress to a stable lesion can be divided into three phases: (1) freeze/thaw phase, (2) 
haemorrhagic and inflammatory phase, and (3) replacement fibrosis phase [24].
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1. Freeze/thaw phase.
Intracellular and extracellular ice formation vary in size and location depending on tissue 
type, proximity to the cryoprobe, and the presence of blood flow during cryoablation. Ice 
crystals, themselves, do not cause mechanical disruption. They do not penetrate the cell 
membrane, but induce compression and distortion of adjacent cytoplasmic components 
[25, 26]. Irreversible injury to mitochondria is a consequence of increased membrane per-
meability during the thaw phase [27]. The damage to the mitochondrial membrane leads 
to membrane lipid peroxidation and enzyme hydrolysis. At this point, mitochondria be-
come irreversibly deenergized [28]. In the heart, the application of cryoprobe to myocar-
dium results in the formation of an elliptical hemispheroid lesion [29]. During the thawing, 
the myocytes get swollen and the myofilaments are extremely stretched.
2. Haemorrhagic and inflammatory phase.
The second phase of myocardial injury following cryoablation is characterized by the de-
velopment of haemorrhage [29], oedema, and inflammation [30], which are found within 
48 hours after thawing. Harrison et al. reported the histologic changes following cryoabla-
tion to the atrioventricular node [31]. One week after the procedure, microscopy showed 
necrosis of myocardial cells and conduction fibres, a polymorphonuclear leukocytic infil-
trate and marked haemorrhage in the peripheral lesion.
3. Replacement fibrosis phase.
The last phase in the evolution of a stable cryolesion is detected at 2–4 weeks after the cry-
oablation. At this point, the cryolesions consist of dense collagen and fat infiltration along 
with many small blood vessels. Harrison et al. reported that, 1 month after the procedure, 
the lesion had been replaced by dense fibrotic connective tissue [31].
3.3. Electrophysiologic effects of cryoablation on the heart
Jensen et al. developed an experimental myocardial injury model using cryoinjury in dogs [32]. 
Their histologic examination showed that the cellular pattern or healing myocardial cryole-
sions was similar to that of a healing myocardial infarction, but with less variability. Several 
papers reported that cryolesions have low arrhythmogenic potential in canine models [33–35].
Holman et al. reported the decrease of electrogram amplitude in cryolesions [33]. The decrease 
in amplitude reflects epicardial ice insulation or inhibition of myocardial electrical potential. 
More than 70% decrease in absolute amplitude from control potentials was predictive of cel-
lular death. Klein et al. demonstrated that the cryolesions are sharply demarcated from nor-
mal myocardium and does not disrupt the surrounding anatomy [34]. The chronic cryolesion 
behaves electrophysiologically like an inert plug with no disruption of surrounding activa-
tion. Ventricular ectopic activity disappeared in cryolesions after 1 week of the cryoablation.
In conclusion, the cryothermal energy can create discrete, structurally intact, and electrically 
inert foci in the myocardium. That is, the electrophysiologic mechanism for a cryoablation is 
considered to be a useful therapeutic modality in the treatment of cardiac arrhythmias.
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3.4. Cryoablation device
Cryothermal energy is delivered to myocardial tissue by using a cryoprobe. Cryoablation 
devices create an inflammatory response (cryonecrosis) that blocks the electrical conduction 
pathway by freezing target tissues.
There are two commercially available cryoablation probes for surgical treatment of cardiac 
arrhythmias. AtriCure Inc. (Mason, OH) has provided cryoICE probe, which uses a 10 cm 
malleable probe on a 20 cm shaft. It utilizes nitrous oxide (N2O) to create continuous transmu-ral lesions that block propagation of atrial activation. The cryoFORM is a latest generation of 
cryoablation probe, which is made from stainless steel and has a corrugated surface, a design 
that provides a high flexibility [36] (Figure 2).
Medtonic Inc. (Minneapolis, MN) has developed Cardioblate CryoFlex surgical ablation 
probes, which utilize argon-powered cryoablation (Figure 3). This is a malleable probe easily 
shaped by hand, and reaches temperature of approximately −150°C. This device is currently 
approved for use in surgical ablation for AF in Europe but not in the United States.
3.5. Transmurality of cryoablation
Kettering et al. created a successful, a right atrial septal linear lesion with cryocatheter in pigs 
[37]. The bipolar voltage map demonstrated very low potentials along the ablation line and a 
sharply demarcated ablation area. However, they concluded that creating a transmural lesion 
and a complete conduction block remains an unsolved problem. Wadhwa et al. reported 
that successful transmurality was achieved with catheter cryoablation in the canine ventricle 
[38]. Masroor et al. reported that endocardial hypothermia was achieved with epicardial 
Figure 2. Illustration of the flexibility of the cryoFORM ablation probe. The length of the active site of the malleable 
probe surface is adjustable by the movable shaft cover (Reproduced with permission from AtriCure, Inc.).
Figure 3. Illustration of the Cardioblate CryoFlex ablation device (Reproduced with permission from Medtronic, Inc.).
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Figure 4. Illustration of the bipolar radiofrequency clamp (Reproduced with permission from AtriCure, Inc.).
cryoablation on a beating heart model in pigs [39]. Schill et al. reported that the latest cryoab-
lation probe produced transmural lesions in 97% of the arrested heart in an ovine model [40].
However, the transmurality created by surgical cryoablation in the human tissue has not been 
well studied.
4. Radiofrequency ablation
4.1. Introduction of radiofrequency ablation
Since Haissaguerre et al. demonstrated the efficacy of radiofrequency ablation for paroxysmal 
atrial fibrillation [20], radiofrequency has become the standard treatment for both catheter-
based ablation and surgical ablation for cardiac arrhythmias. Chiappini et al. reported the 
efficacy of radiofrequency ablation in the patients who had chronic atrial fibrillation, and it 
was as effective as cut-and-sew Maze procedure [41, 42].
However, lesions created by hyperthermia have a potential risk of tissue disruption that can 
result in perforation of surrounding tissue, pulmonary stenosis, and thromboembolic stroke 
[43, 44].
4.2. Bipolar versus unipolar radiofrequency
Bugge et al. compared the transmurality of ablated lesions in ovine hearts using irrigated 
bipolar and unipolar radiofrequency ablation [45]. They reported that bipolar radiofrequency 
was superior in creating transmurality, but both devices failed to produce consistent transmu-
rality using the epicardial beating heart technique. Gonzalez-Suarez et al. also demonstrated 
that bipolar is more effective than unipolar in achieving transmurality in vitro [46]. However, 
the superiority of bipolar over unipolar in human has not been established.
AtriCure Inc. (Mason, OH) has provided bipolar radiofrequency ablation device, which has 
stainless steel shaft and jaws to maintain consistent tissue pressure and precise electrode 
alignment across the entire length of the jaws (Figure 4).
Medtonic Inc. (Minneapolis, MN) has provided Cardioblate system, which utilizes irrigated 
bipolar radiofrequency energy to ablate tissue transmurally (Figure 5).
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4.3. Histopathological changes after radiofrequency ablation
Heat propagation is based on both resistive and passive mechanisms. In the early phase of 
radiofrequency ablation, tissue is heated to 50–60°C resulting in coagulation and irrevers-
ible destruction of cell and collagen structures. Ablation of the peripheral part of the lesion 
results from passive heating with the same effect of irreversible damage. Both resistive and 
passive heating propagate in all directions so that the tissue lesion becomes similar in depth 
and width [41]. Once the transmurality is achieved with radiofrequency ablation, there is no 
proarrhythmic activity found in the scar tissue [47].
Aupperle et al. reported the histological findings in experimental atrial ablation in sheep [48]. 
They reported that epicardial bipolar radiofrequency resulted in intensive endocardial necro-
ses and severe sharply demarcated transmural myocardial necroses. Similarly, endocardial 
unipolar radiofrequency resulted in severe endocardial necroses as well as intense, transmu-
ral, and well demarcated myocardial necroses. Ba et al. also reported that radiofrequency 
resulted in myocyte necrosis in sheep, and radiofrequency was as effective as cryotherapy 
[49]. Gaynor et al. performed surgical ablation using bipolar radiofrequency energy source 
in pigs [50]. They reported histological assessment that showed all lesions created by bipolar 
radiofrequency were transmural and there were no stenosis of the coronary vessels or inju-
ries to the valves.
4.4. Transmurality of radiofrequency ablation
Although bipolar radiofrequency produces transmural linear lesions in the animals [51, 52], 
transmurality is not always achieved in human, as several papers reported [53, 54]. Deneke 
et al. reported that transmurality of the ablated lesions could only be found in 75% in human 
atria [55]. Kasirajan et al. reported the histopathological findings in three human patients who 
had autopsy after surgical ablation [53]. Their microscopic examination showed that (1) surgi-
cally ablated lesions showed not only transmural but also nontransmural lesions (Figure 6), 
(2) chronic ischemic and fibrotic changes existed in the myocardium of the patients who had 
long-standing persistent AF and mitral regurgitation, and (3) acute bi-directional electrical 
conduction block did not guarantee transmurality of ablation lesions. They assumed that the 
underlying disease process prevented the creation of transmural lesions. The wall thickness 
Figure 5. Illustration of the Cardioblate clamp, which utilizes bipolar radiofrequency energy source (Reproduced with 
permission from Medtronic, Inc.).
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of the atrium has been known to affect the transmurality [45]. Therefore, repeated radiofre-
quency ablation is recommended, especially in thick lesions [56, 57].
Ventosa-Fernandez et al. reported the histologic evidence of transmurality 4 years after bipo-
lar radiofrequency ablation [58].
5. Conclusions
Recently, the conventional cut-and-sew Cox-Maze procedure has been replaced by alterna-
tive energy sources in the surgical treatment of atrial fibrillation. Cryoablation and radiofre-
quency ablation have been playing an important role in this field. Both energy sources have 
been shown to be effective in treating atrial fibrillation. However, despite the technological 
advancement, there remains uncertainty of transmurality in human tissue, especially when 
patients have underlying disease. Lack of transmurality may result in failure of surgical abla-
tion. Further histopathological studies will be necessary in assessing the effectiveness of using 
alternative energy sources. Moreover, a further technological advancement in achieving reli-
able transmurality should be warranted in the future.
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Figure 6. (a) Day 6 of surgical ablation. Extensive fibrosis in atrial tissue (blue) with necrotic myocardium (purple), and 
viable muscle (red). (Mason trichrome stain: magnification ×40.) (b) Day 18 of surgical ablation. Healing with coagulative 
necrosis and wavy bundles of collagen with few viable cells in between (hematoxylin and eosin: magnification ×100.).
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